50 related articles for article (PubMed ID: 28207517)
1. Treatment of medullary thyroid carcinoma with apatinib: A case report and literature review.
Cai S; Deng H; Chen Y; Wu X; Guan X
Medicine (Baltimore); 2017 Dec; 96(50):e8704. PubMed ID: 29390263
[TBL] [Abstract][Full Text] [Related]
2. Response to "lymph node ratio independently associated with postoperative thyroglobulin levels in papillary thyroid".
Akhtar A; Akhtar R; Zaidi E
Oral Oncol; 2024 Mar; 150():106718. PubMed ID: 38350260
[No Abstract] [Full Text] [Related]
3. Pulmonary injury after radioactive iodine therapy in pediatric papillary thyroid cancer: a case report.
Halada S; Leftin Dobkin S; Baran JA; Sisko L; Robbins SL; Rapp JB; Young LR; Bauer AJ
Horm Res Paediatr; 2023 Nov; ():. PubMed ID: 37956658
[TBL] [Abstract][Full Text] [Related]
4. Heart failure as first sign of development of cardiac metastases in a patient with diagnosis of papillary thyroid carcinoma on treatment with tyrosine-kinase inhibitors: differential diagnoses and clinical management.
Bruixola G; Segura A; Caballero J; Andrés A; Reche E; Escoín C; Díaz-Beveridge R
Case Rep Oncol; 2014 May; 7(2):591-9. PubMed ID: 25298765
[TBL] [Abstract][Full Text] [Related]
5. The Role of Thyroglobulin in Preoperative and Postoperative Evaluation of Patients With Differentiated Thyroid Cancer.
Li S; Ren C; Gong Y; Ye F; Tang Y; Xu J; Guo C; Huang J
Front Endocrinol (Lausanne); 2022; 13():872527. PubMed ID: 35721746
[TBL] [Abstract][Full Text] [Related]
6. Unstimulated Serum Thyroglobulin Levels after Thyroidectomy and Radioiodine Therapy for Intermediate-Risk Thyroid Cancer Are Not Always a Reliable Marker of Lymph Node Recurrence: Case Report and a Lesson for Clinicians.
Foppiani L; Sola S; Cabria M; Bottoni G; Piccardo A
Case Rep Endocrinol; 2020; 2020():8827503. PubMed ID: 33101736
[TBL] [Abstract][Full Text] [Related]
7. Thyroglobulin "Nonsecretor" Metastatic Poorly Differentiated Thyroid Carcinoma with Noniodine Concentrating Disease and Aggressive Clinical Course: A Clinical Case Series.
Kalshetty A; Basu S
Indian J Nucl Med; 2018; 33(3):218-223. PubMed ID: 29962718
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of prophylactic central compartment neck dissection in the treatment of clinically node-negative papillary thyroid cancer patients.
Gambardella C; Tartaglia E; Nunziata A; Izzo G; Siciliano G; Cavallo F; Mauriello C; Napolitano S; Thomas G; Testa D; Rossetti G; Sanguinetti A; Avenia N; Conzo G
World J Surg Oncol; 2016 Sep; 14(1):247. PubMed ID: 27644091
[TBL] [Abstract][Full Text] [Related]
9. [Investigating patients with differentiated thyroid carcinoma and elevated serum thyroglobulin but negative whole-body scan].
Rosário PW; Maia FC; Barroso AL; Purisch S
Arq Bras Endocrinol Metabol; 2005 Apr; 49(2):246-52. PubMed ID: 16184253
[TBL] [Abstract][Full Text] [Related]
10. A rare case report of very low thyroglobulin and a negative whole-body scan in a patient with a solid variant of papillary thyroid carcinoma with distant metastases.
Li W; Sun D; Ming H; Zhang G; Tan J
Medicine (Baltimore); 2017 Feb; 96(7):e6086. PubMed ID: 28207517
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.
Lima N; Cavaliere H; Tomimori E; Knobel M; Medeiros-Neto G
J Endocrinol Invest; 2002 Feb; 25(2):110-5. PubMed ID: 11929080
[TBL] [Abstract][Full Text] [Related]
12. Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin.
Hughes DT; Laird AM; Miller BS; Gauger PG; Doherty GM
Ann Surg Oncol; 2012 Sep; 19(9):2951-7. PubMed ID: 22526913
[TBL] [Abstract][Full Text] [Related]
13. Papillary thyroid carcinoma patients assessed to be at low or intermediary risk after primary treatment are at greater risk of long term recurrence if they are thyroglobulin antibody positive or do not have distinctly low thyroglobulin at initial assessment.
Soyluk O; Boztepe H; Aral F; Alagol F; Özbey NC
Thyroid; 2011 Dec; 21(12):1301-8. PubMed ID: 22136265
[TBL] [Abstract][Full Text] [Related]
14. Pathological evaluation of differentiated thyroid cancer in patients with positive serum thyroglobulin and negative iodine scan.
Ansari M; Babaei AA; Shafiei B; Javadi H; Assadi M; Nabipour I; Asli IN
Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1925-9. PubMed ID: 25010624
[TBL] [Abstract][Full Text] [Related]
15. Radioiodine whole-body scans, thyroglobulin levels, 99mTc-MIBI scans and computed tomography: results in patients with lung metastases from differentiated thyroid cancer.
Küçük ON; Gültekin SS; Aras G; Ibiş E
Nucl Med Commun; 2006 Mar; 27(3):261-6. PubMed ID: 16479246
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
